Werth Ventures
Werth Ventures, established in 2009 and located in Woodbridge, Connecticut, is an angel investor focused on startup companies in the pharmaceutical, veterinary, and medical device sectors. The firm has played a pivotal role in the development of various medical innovations, including a TrkA specific inhibitor for pain treatment and a first-line therapy for gastroparesis. Their investments also support a generic company specializing in injectable products and a veterinary firm dedicated to small companion animal medicines. Currently, Werth Ventures is funding projects aimed at developing cancer treatment drugs, addressing cardiovascular issues, and creating topical pain relief medications. Additionally, the firm is backing advancements such as point-of-care test kits for rapid concussion detection, innovative autoinjector technologies, and specialized imaging for diagnosing brain damage linked to Alzheimer's and CTE. These initiatives, upon successful approval, are expected to lead to significant medical breakthroughs.
Torigen Pharmaceuticals
Venture Round in 2022
Torigen Pharmaceuticals is dedicated to advancing cancer care for companion animals through innovative treatment options. Founded in 2013 and based in Farmington, Connecticut, the company focuses on developing immunotherapy solutions, particularly an experimental autologous cancer vaccine. This vaccine aims to activate the immune system to target specific tumor-associated antigens present on cancer cells, allowing for more effective detection and treatment of tumors. By providing alternatives to traditional, invasive methods such as surgeries and chemotherapy, Torigen seeks to improve the quality of life for pets facing cancer. The company builds on years of scientific research and is committed to pushing the boundaries of veterinary oncology.
Bastion Health
Seed Round in 2022
QRfertile LLC, based in Farmington, Connecticut, develops and manufactures a male fertility test kit that enables customers to perform tests at home. Founded in 2018, the company provides a comprehensive platform that not only allows men to assess their fertility but also connects them with physicians for guidance on improving reproductive health. QRfertile's offerings aim to make male health care more accessible and affordable, addressing a significant need in the market. By integrating modern technology with health consultations, the company enhances patient engagement and facilitates better health outcomes for men, ultimately aiming to improve their overall lifestyle and well-being.
Bastion Health
Seed Round in 2020
QRfertile LLC, based in Farmington, Connecticut, develops and manufactures a male fertility test kit that enables customers to perform tests at home. Founded in 2018, the company provides a comprehensive platform that not only allows men to assess their fertility but also connects them with physicians for guidance on improving reproductive health. QRfertile's offerings aim to make male health care more accessible and affordable, addressing a significant need in the market. By integrating modern technology with health consultations, the company enhances patient engagement and facilitates better health outcomes for men, ultimately aiming to improve their overall lifestyle and well-being.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.